La kinase PKR contrôle la signalisation cérébrale anormale au cours de l’obésité expérimentale
Mariko Taga(Columbia University Irving Medical Center), Jacques Hugon(Inserm), Malha Sadoune(Inserm), François Mouton‐Liger(Inserm), Marion Tible(Inserm), Sylvie Thomasseau(Inserm), James A. R. Nicoll(University of Southampton), Sarah Gourmaud(Inserm), Delphine Boche(Southampton General Hospital), Claire Paquet(Université Paris Cité), Jenny Norman(University of Southampton)
Cited by 0
Related Papers
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
|PLoS Medicine|2017|610
Neuroinflammation in Alzheimer disease
|Nature reviews. Immunology|2024|401
Acutely Decompensated Heart Failure with Preserved and Reduced Ejection Fraction Present with Comparable Haemodynamic Congestion
|European Journal of Heart Failure|2017|160
Effects of Sacubitril/Valsartan on Neprilysin Targets and The Metabolism of Natriuretic Peptides in Chronic Heart Failure: A Mechanistic Clinical Study
|European Journal of Heart Failure|2018|153